Status:
UNKNOWN
Exophthalmometry With 3D Face Scanners
Lead Sponsor:
University of Zurich
Conditions:
Exophthalmos
Graves Ophthalmopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study investigates diagnostic methods to measure eyeball protrusion with a smartphone face scanner compared to the traditional Hertel exophthalmometer. The study aims to validate a new reliable, ...
Detailed Description
BACKGROUND: Accurate and reproducible measures of abnormal eyeball protrusion are important for diagnosing different causes of exophthalmos, as well as following patients with Grave's orbitopathy and ...
Eligibility Criteria
Inclusion
- Written informed consent
- Able to cooperate with the study investigations (hearing, comprehension)
- Exophthalmos (Grave's disease, orbital tumors, orbital inflammation, orbital fractures, rare causes (congenital, e.g. microphthalmos)
- health controls
Exclusion
- Unable to sign informed consent
- Unable to cooperate with the examinations (hearing loss, neurological deficits)
Key Trial Info
Start Date :
August 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04704414
Start Date
August 14 2019
End Date
December 31 2022
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology Department, University Hospital Zurich
Zurich, Switzerland, CH-8091